Healthcare

Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

SHANGHAI, Dec. 31, 2025, 20:14 GMT-05

QimingVenturePartners

Read full article →

Cell and Gene Therapy Market to Exceed US$105B by 2033, Driving Strategic Value Across Healthcare Portfolios | According to DataM Intelligence

AUSTIN, Texas and TOKYO, Dec. 29, 2025, 06:40 GMT-05

DATAM-INTELLIGENCE

Read full article →

Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes Phase 3 trial following FDA alignment and guidance

STOCKHOLM, Dec. 29, 2025, 02:49 GMT-05

DIAMYD-Clinical-Trial

Read full article →

Waters Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026

MILFORD, Mass., Dec. 23, 2025, 11:00 GMT-05

Waters-Corp-cca

Read full article →

Henlius CEO Dr. Jason Zhu to Deliver a Keynote Presentation at JPM 2026

SHANGHAI, Dec. 23, 2025, 09:05 GMT-05

Henlius-JPM-2026

Read full article →

TraceLink Wins 2025 Merit Award -- Recognized for Healthcare Innovation for the Third Consecutive Year

BOSTON, Dec. 22, 2025, 10:00 GMT-05

TraceLink-Inc.

Read full article →

XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments

DUBAI, UAE, Dec. 22, 2025, 03:00 GMT-05

XRP-HEALTHCARE

Read full article →

Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast cancer subtype

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 22, 2025, 03:00 GMT-05

Menarini-Treatment

Read full article →

Curasight Announces Successful Dosing of First Patient in Phase 1 trial with uTREAT® in Brain Cancer

COPENHAGEN, Denmark, Dec. 18, 2025, 13:50 GMT-05

Curasight-Announces

Read full article →

Global Temperature Controlled Package for Pharmaceutical Market to Reach USD 9.34 Billion by 2029, Driven by Biologics and Vaccine Demand | Valuates Reports

BANGALORE, India, Dec. 18, 2025, 10:15 GMT-05

VALUATES-REPORTS

Read full article →

Novo Nordisk files for FDA approval of CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues for weight management

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, Dec. 18, 2025, 08:00 GMT-05

NovoNordisk-FDA-File

Read full article →

Liquid Biopesticides Market worth $11.50 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Dec. 18, 2025, 06:59 GMT-05

MarketsandMarkets

Read full article →

Vantage Foundation Spreads Festive Cheer to Children with Starlight Sydney Initiative

SYDNEY, Dec. 18, 2025, 03:37 GMT-05

Vantage-Children

Read full article →

A hospital in Barcelona successfully operates on a 10-year-old Romanian boy with a severe congenital heart defect that prevented him from walking

BARCELONA, Spain, Dec. 18, 2025, 02:00 GMT-05

SJD-Barcelona-Operate

Read full article →

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight

LAS VEGAS, Dec. 17, 2025, 17:31 GMT-05

DelveInsight-Business

Read full article →

Jazz Pharmaceuticals to Participate in Upcoming Investor Events

DUBLIN, Dec. 17, 2025, 16:15 GMT-05

Jazz-Pharmaceuticals

Read full article →

Breast Cancer Drugs Market to Reach USD 57.1 Billion by 2031 as Precision Oncology and Targeted Therapies Redefine Treatment Outcomes

AUSTIN, Texas and TOKYO, Dec. 17, 2025, 11:00 GMT-05

DATAM-INTELLIGENCE

Read full article →

Disease-Modifying Therapies Market to Surpass USD 112.6 Billion by 2033 as Biologic Innovation Redefines Long-Term Disease Control

AUSTIN, Texas and TOKYO, Dec. 17, 2025, 10:20 GMT-05

DATAM-INTELLIGENCE

Read full article →

numares Health enters ASEAN region with regulatory approval in Malaysia and first contract win for AXINON® LDLp Test System

REGENSBURG, Germany, Dec. 17, 2025, 03:30 GMT-05

numares-Health-ASEAN

Read full article →

Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology

UXBRIDGE, England, Dec. 17, 2025, 03:01 GMT-05

Norgine

Read full article →